根据美国证券交易委员会（SEC）最新披露的文件，Jaguar Health Inc（纳斯达克：JAGX）宣布其子公司Napo Pharmaceuticals已与Woodward Specialty达成一项重要财务协议。
根据协议条款，Woodward Specialty将向Napo支付总额高达1800万美元的预付款项。值得注意的是，其中1600万美元将在协议正式生效当日立即支付，其余款项将按约定条件分期履行。
这笔资金的注入预计将为Napo的运营发展和研发活动提供有力支持，同时也体现了合作伙伴对Napo业务前景的信心。此次交易细节已通过8-K表格提交至SEC备案，标志着双方合作进入实质性阶段。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.